Brain training app that could help schizophrenia sufferers live a normal life: Patients who played game regularly for a month were four times better at remembering things
A new brain training app developed to help improve the memory of people with schizophrenia could save taxpayers thousands of pounds, a study has claimed.
New NHS death guidelines ‘worse than Liverpool Care Pathway’
New NHS guidelines on end of life care are worse than the Liverpool Care Pathway and could push more patients to an early grave, a leading doctor has warned.
Pancreatic cancer urine test could save thousands of lives every year
Urine tests to detect a “signature” of protein could improve early diagnosis of pancreatic cancer – potentially saving thousands of lives every year.
Britain not sunny enough for healthy vitamin D levels, say experts
People in Britain should boost their vitamin D intake with supplements because of a lack of bright sunshine to provide it naturally, government health advisers have suggested.
Gill Pharaoh: Healthy former nurse, 75, passes away at assisted dying clinic after deciding old age is ‘awful’
Gill Pharaoh, 75, passed away at the Lifecircle clinic in Basel, Switzerland, where she was joined by John, her partner of 25-years.
Prostate cancer: Five types ‘found’
Scientists have identified five types of prostate cancer, each with a distinct genetic signature.
HIV flushed out by cancer drug
A strategy known as “kick and kill” is thought to be key to curing HIV – the kick would wake up the dormant HIV allowing the drugs to kill it.
The drug to slow Alzheimer’s?
Provisional data suggests that the drug solanezumab may slow the progression of the disease by 34%.
Councils must act on loneliness triggers, campaigners warn
The Campaign to End Loneliness (CTEL), partners in The Yorkshire Posts Loneliness: The Hidden Epidemic campaign is calling on local authorities to take the lead on reducing and preventing loneliness, which can be as damaging to health as smoking 15 cigarettes a day.
Is the ‘manopause’ more widespread than we thought?
Currently, those suffering from ‘Low Testosterone’ can receive TRT on the NHS, but the results of this report suggest that the net of eligibility could be cast wider.